Applied Genetic Technologies Corporation investor relations material

Listen to the latest call from Applied Genetic Technologies Corporation

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. It focuses on developing adeno-associated virus (AAV)-based gene therapies to treat orphan diseases, including X-linked retinoschisis, achromatopsia, X-linked retinitis pigmentosa, and ocular albinism. Applied Genetic Technologies Corporation was founded in 1999 and is headquartered in Alachua, Florida.

Dig deeper into the Applied Genetic Technologies Corporation fundamentals on Quartr.